Pricing Log in Create free account

Biodexa Pharmaceuticals PLC Unsponsored ADR (BDRX) vs CDT Equity Inc. (CDT)

Biodexa Pharmaceuticals PLC Unsponsored ADR and CDT Equity Inc. are both Biotechnology companies. Biodexa Pharmaceuticals PLC Unsponsored ADR is the larger, with a market value of $440.0K against $240.0K — 1.8× the size. CDT Equity Inc. has the higher net margin (0.00% vs −1,155.7%) and the lower return on invested capital (−21.3% vs 0.00%). Across the 9 metrics below, Biodexa Pharmaceuticals PLC Unsponsored ADR leads on 6 and CDT Equity Inc. on 3.

Valuation

Metric BDRX CDT Biotechnology median
P/E n/m n/m 8.50
P/S n/m n/m 9.71
P/B n/m n/m 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.20 n/m 0.64
EV/Sales (2.81) n/m 9.21
Earnings yield (555.04%) 372,911,481.96% (33.15%)
Free cash flow yield 0.00% (232,570.42%) (25.50%)

Profitability

Metric BDRX CDT Biotechnology median
Gross margin 0.00% — 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin (1,155.70%) 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 0.00% (69.68%) (56.36%)
Return on assets 0.00% (55.16%) (48.04%)
Return on invested capital 0.00% (21.28%) 0.00%

Growth

Metric BDRX CDT Biotechnology median
Revenue growth (TTM) 60.22% — 6.02%
EPS growth (last fiscal year) 89.68% 52.16% 30.26%
Revenue growth, 5-year CAGR (28.78%) — 9.41%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric BDRX CDT Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 2.41 0.13 4.72
Net debt to EBITDA 1.00 0.05 0.96

Dividend

Metric BDRX CDT Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric BDRX CDT Biotechnology median
Market cap 440.00k 240.00k 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack